Search
Research
Efficacy of the MiniMed™ 670G hybrid closed loop system in managing postprandial glucose excursion with high protein high fat foods in children and adolescents under free-living conditionsHigh protein high fat meals are considered “difficult” foods because they can cause prolonged hyperglycemia after ingestion. The potential of hybrid closed loop therapy in managing postprandial glucose excursions with these difficult foods remains unknown. This pilot study aimed to explore the impact of manual mode in standard insulin pump therapy and auto mode with hybrid closed loop pump therapy in managing glucose excursions caused by HPHF foods and to obtain feedback from families about each mode.
Research
Contribution of an intrinsic lag of continuous glucose monitoring systemsCurrent continuous glucose monitoring (CGM) systems measure glucose levels in the interstitial fluid to estimate blood glucose concentration.
Research
Type 2 Diabetes in Indigenous Australian childrenRates of type 2 diabetes are higher among Indigenous than non-Indigenous Australian children and adolescents.
Research
Exercise alone reduces insulin resistance in obese children independently of changes in body compositionThe number of obese children with insulin resistance and type 2 diabetes is increasing, but the best management strategy is not clear.
Research
Diabetes, Metabolism and Clinical SciencesListed are all The Kids Research Institute Australia research teams involved in our Diabetes and Obesity Program. This program sits under the Chronic and Severe Diseases research theme.
Research
Type 1 and Type 2 Diabetes DNA bankA register which stores demographic and clinical data on all patients attending the diabetes clinic at Princess Margaret Hospital
Research
Sprint proof of concept studyThis study will evaluate the effect of two types of aerobic exercise
Research
The effect of oral insulin on subcutaneous insulin requirements and glycaemia in T1DMLiz Tim Davis Jones MBBS FRACP PhD MBBS DCH FRACP MD Theme Head, Chronic & Severe Diseases; Clinical Lead, Diabetes and Obesity Research Co-head,
News & Events
What life is like living with type 1 diabetesEvery decision a child with type 1 diabetes makes can impact on their blood glucose levels.
Research
Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 DiabetesAdvanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.